Fox Run Management L.L.C. Has $533,000 Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Fox Run Management L.L.C. decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 27.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,796 shares of the medical device company’s stock after selling 2,169 shares during the period. Fox Run Management L.L.C.’s holdings in Cooper Companies were worth $533,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in COO. Byrne Asset Management LLC bought a new stake in Cooper Companies during the 4th quarter worth about $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $34,000. Brown Brothers Harriman & Co. raised its holdings in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares in the last quarter. West Financial Advisors LLC bought a new stake in Cooper Companies during the fourth quarter worth about $49,000. Finally, Atala Financial Inc acquired a new position in Cooper Companies during the fourth quarter valued at approximately $51,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.4 %

Shares of COO opened at $83.70 on Wednesday. The firm’s 50-day simple moving average is $89.80 and its 200 day simple moving average is $97.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $16.74 billion, a P/E ratio of 42.92, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Stifel Nicolaus cut their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Friday, March 7th. Piper Sandler restated an “overweight” rating and set a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, Robert W. Baird reduced their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.